MRDALL:

Valerie Tran1, Kiarash Salafian2, Kenan Michaels2

  • 1Division of Hematology and Oncology, Department of Medicine, The University of Virginia, Charlottesville, VA, USA.

概括

可测量的残留疾病 (MRD) 监测对于费城染色体阳性急性淋巴细胞白血病 (Ph + ALL) 至关重要. 实现MRD负面性显著改善了患者的治疗结果,并指导了治疗决策.